Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Jiulong Hisince Pharmaceutical is a comprehensive pharmaceutical enterprise based in Zibo, China, specializing in the development and large-scale production of active pharmaceutical ingredients (APIs) and finished dosage forms. The company is a prominent leader in the antibiotic sector, particularly recognized for its extensive portfolio of third-generation cephalosporins such as Cefixime and Cefdinir. Beyond anti-infectives, the firm manufactures a variety of treatments for cardiovascular and gastrointestinal conditions, maintaining international Good Manufacturing Practice (GMP) standards. With a strong emphasis on vertical integration, the company manages the entire production chain from chemical synthesis to final packaging. Its products are widely distributed across domestic Chinese markets and exported to numerous global regions, establishing it as a key supplier in the generic pharmaceutical industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Jiulong Hisince Pharmaceutical.